Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Predictive Value of 3-Month Early Molecular Response in New Chronic Phase Chronic Myeloid Leukemia Patients Treated with Radotinib

Blood (2015) 126 (23): 4053.

https://doi.org/10.1182/blood.V126.23.4053.4053

Published: 2015

Journal Articles

Comparable Outcomes with Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients with or without Aplastic Anemia in a Prospective Korean PNH Registry

Jun Ho Jang, Jin Seok Kim, MD PhD, Deog-Yeon Jo, MD PhD, Je-Hwan Lee, MD PhD, Chul Won Choi, MD PhD, Hyeoung Joon Kim, MD PhD, Jong-Ho Won, MD PhD, Joo Seop Chung, MD PhD, Hawk Kim, MD PhD, Jae-Hoon Lee, MD PhD, Sang Kyun Sohn, MD PhD, Jeong A Kim, MD PhD, Jong Wook Lee, MD PhD

Blood (2015) 126 (23): 4789.

https://doi.org/10.1182/blood.V126.23.4789.4789

Published: 2015

Journal Articles

Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients: 12 Months Result of Phase 3 Clinical Trial

Blood (2015) 126 (23): 476.

https://doi.org/10.1182/blood.V126.23.476.476

Published: 2015

Journal Articles

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia

Blood (2015) 126 (6): 746–756.

https://doi.org/10.1182/blood-2015-03-636548

Published: 2015

Includes: Supplemental data

Journal Articles

Efficacy and Safety of Deferasirox Estimated By Serum Ferritin and Labile Plasma Iron Levels in Patients with Aplastic Anemia, Myelodysplastic Syndrome, or Hematologic Malignancy with Transfusional Iron Overload

Il hwan Kim, MD, Young Don Joo, MD PhD, Joon Ho Moon, MD PhD, Sung Nam Lim, MD, Sang Kyun Sohn, MD PhD, Gyeong Won Lee, Ho Sup Lee, Ki Young Kwon, MD PhD, Sung Hyun Kim, Kyung Tae Park, Joo Seop Chung, MD PhD, Won Sik Lee, MD PhD, Sang Min Lee, MD PhD, Myung Soo Hyun, MD PhD, Hawk Kim, Hun-Mo Ryoo, MD, Sung Hwa Bae

Blood (2014) 124 (21): 2676.

https://doi.org/10.1182/blood.V124.21.2676.2676

Published: 2014

Journal Articles

Ineffective Corticosteroid Treatment for Hemolysis Management of Paroxysmal Nocturnal Hemoglobinuria

Jong Wook Lee, MD PhD, Jun Ho Jang, MD PhD, Je-Hwan Lee, MD PhD, Deog-Yeon Jo, MD PhD, Jin Seok Kim, Yong Park, MD PhD, Sang Kyun Sohn, MD PhD, Jun Sung Park, MD PhD, Chul Won Choi, MD PhD, Joo Seop Chung, MD PhD, Jae Hoon Lee, MD PhD, Jeong A Kim, MD PhD, Jong-Ho Won, MD PhD

Blood (2014) 124 (21): 5151.

https://doi.org/10.1182/blood.V124.21.5151.5151

Published: 2014

Journal Articles

Role Of Hypomethylating Agents For Patients With Lower-Risk Myelodysplastic Syndrome Defined By IPSS and IPSS-R

Joon Ho Moon, M.D., Ph.D, Sang Kyun Sohn, MD, PhD, Jae Sook Ahn, MD, Yeo-Kyeoung Kim, MD, PhD, Hyeoung Joon Kim, MD, PhD, Moo-Kon Song, MD, Ho-Jin Shin, Joo-Seop Chung, MD, PhD, Ik Chan Song, MD, Deog-Yeon Jo, MD, PhD, Sung Nam Lim, MD, Ho Sup Lee, Yang Soo Kim, MD, PhD, Sung Hwa Bae

Blood (2013) 122 (21): 2782.

https://doi.org/10.1182/blood.V122.21.2782.2782

Published: 2013

Journal Articles

Restrospective Multicenter Study Evaluating Efficacy and Safety of Dasatinib and Nilotinib in Patients with Imatinib-Resistant or –intolerant Chronic Myeloid Leukemia in Chronic Phase: Korean CML Working Party

Blood (2012) 120 (21): 1691.

https://doi.org/10.1182/blood.V120.21.1691.1691

Published: 2012

Journal Articles

Metabolic Tumor Volume Has Potential Clinical Impact Compared with SUVmax in Primary Gastrointestinal Diffuse Large B Cell lymphoma

Moo-Kon Song, Joo-seop Chung, Ho-Jin Shin, Joon Ho Moon, Jeong Ok Lee, Ho Sup Lee, MD, Sang-Min Lee, Gyeong Won Lee, Suee Lee

Blood (2011) 118 (21): 4983.

https://doi.org/10.1182/blood.V118.21.4983.4983

Published: 2011

Journal Articles

Early Response to Botezomib Combined Chemotherapy Can Be Helpful for Prediction of Progression Free Survival in Patients with Multiple Myeloma Who Were Ineligible for Stem Cell Transplantation

Ho Sup Lee, Yang Soo Kim, Kihyun Kim, Jin Seok Kim, Hyo Jung Kim, MD, PhD, Chang-Ki Min, Cheolwon Suh, MD, Hyeon-Seok Eom, Sung-Soo Yoon, MD, PhD, Jae Hoon Lee, MD, Min Kyoung Kim, Sung Hyun Kim, MD, PhD, Sung Hwa Bae, Yeung-Chul Mun, Deog Yeon Jo, Joo Seop Chung

Blood (2011) 118 (21): 5138.

https://doi.org/10.1182/blood.V118.21.5138.5138

Published: 2011

Journal Articles

The Immunohistochemical Profile and Other Prognostic Factors In Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with R-CHOP

Jorge J Castillo, MD, Brady Beltran, MD, Joo-Seop Chung, MD, Ivana Ilic, MD, Sirpa Leppa, Ritsuko Seki, PhD, Silvia Uccella, MD, Zu-Guang Xia, MD, James N Butera, MD

Blood (2010) 116 (21): 4126.

https://doi.org/10.1182/blood.V116.21.4126.4126

Published: 2010

Journal Articles

Dasatinib for Chronic Phase Chronic Myeloid Leukemia After Failure of Imatinib In Korean Patients.

Ha Yeon Lee, Myung-Hee Chang, Chul Won Jung, Dong Hwan (Dennis) Kim, Won Seog Kim, Seok Jin Kim, MD, PhD, Kihyun Kim, MD, Jun Ho Jang, Sung-Soo Yoon, Kyoo-Hyung Lee, M.D., PhD., Hyeoung Joon Kim, MD, PhD, Joo-Seop Chung, MD, Sang Kyun Sohn

Blood (2010) 116 (21): 4494.

https://doi.org/10.1182/blood.V116.21.4494.4494

Published: 2010

Journal Articles

Clinical Implications of Clonal Cytogenetic Abnormalities of Aquired Aplastic Anemia.

Sung Hyun Kim, Ji Hyun Lee, Kyung A. Kwon, Suee Lee, Sung Yong Oh, Hyuk-Chan Kwon, Jin-Yeong Han, MD, Moo-Kon Song, Joo-Seop Chung, Sang-Min Lee, Young-Don Joo, Ho Sup Lee, MD, Yang Soo Kim, Hyo Jin Kim

Blood (2009) 114 (22): 4217.

https://doi.org/10.1182/blood.V114.22.4217.4217

Published: 2009

Journal Articles

Sequential VAD (Vincristine, Adriamycin, Dexamethasone) and VTD (Bortezomib, Thalidomide, Dexamethasone) Induction Followed by High-Dose Therapy with Autologous Stem Cell Transplantation and Maintenance Treatment with Bortezomib for Newly Diagnosed Multiple Myeloma: Final Analysis of Phase II Trial.

Sung-Soo Yoon, Hye Jin Kim, Joo Seop Chung, HyeonSeok Eom, Jun-Ho Jang, Hye Jin Kang, Cheol Soo Kim, Kihyun Kim, Dongsoon Lee, Jae Hoon Lee, Junglim Lee, Sang Jae Lee, Yoo Hong Min, Chu-Myong Seong, Sang-Kyun Sohn, Cheolwon Suh, Jong-Ho Won

Blood (2008) 112 (11): 3330.

https://doi.org/10.1182/blood.V112.11.3330.3330

Published: 2008

Journal Articles

Comparing Standard IPI with Revised-IPI in Patients with Diffuse Large B-Cell Lymphoma: Which Has a More Differential Potential for Predicting the Outcomes after R-CHOP Chemotherapy.

Deok-Hwan Yang, Jae Sook Ahn, Yeo-Kyeoung Kim, Je-Jung Lee, Young Jin Choi, Ho Jin Shin, Joo-Seop Chung, Joon Ho Moon, Yee Soo Chae, Jong Gwang Kim, Sang Kyun Sohn, Hyeoung-Joon Kim

Blood (2008) 112 (11): 2003.

https://doi.org/10.1182/blood.V112.11.2003.2003

Published: 2008

Journal Articles

Velcade ® , Thalidomide, Dexamethasone (VTD) Followed by Melphalan, Prednisone, Thalidomide (MPT) Maintenance as a First Line Treatment Demonstrates High Response Rates for High-Risk Patients with Multiple Myeloma (MM) Who Are Non-Transplant Candidates: Updated Results of Phase II Trial

HyeonSeok Eom, Yeo-Kyeoung Kim, Joo-Seop Chung, Kihyun Kim, Hyo-Jung Kim, HoYoung Kim, Jong-Youl Jin, Young-Rok Do, Suk-Joong Oh, Cheolwon Suh, Chu-Myong Seong, Chul Soo Kim, Dong Soon Lee, Jae Hoon Lee

Blood (2008) 112 (11): 2785.

https://doi.org/10.1182/blood.V112.11.2785.2785

Published: 2008

Journal Articles

Clinical Efficacy of VEL-CTD (Bortezomib, Cyclophosphamide, Thalidomide, and Dexamethasone) Regimen in Patients with Relapsed or Refractory Multiple Myeloma: A Phase II Study

Yeo-Kyeoung Kim, Je-Jung Lee, Sang-Kyun Sohn, Ho-Jin Shin, Joo-Seop Chung, Young-Jin Choi, Joon-Ho Moon, Yee-Soo Chae, Jong-Gwang Kim, Jae-Sook Ahn, Deok-Hwan Yang, Hyeoung-Joon Kim, the Korean Multiple Myeloma Working Party (KMMWP)

Blood (2008) 112 (11): 3693.

https://doi.org/10.1182/blood.V112.11.3693.3693

Published: 2008

Journal Articles

Allogeneic Stem Cell Transplantation Can Be an Effective Post-Remission Strategy for Acute Myeloid Leukemia Patients Aged Less Than 60 Years with Core Binding Factor: A Nation-Wide Retrospective Study in Korea.

Ho-Jin Shin, Joo Seop Chung, Hyioung-Joon Kim, Sang Kyun Sohn, Yoo Hong Min, Jong-Ho Won, Inho Kim, Je-Hwan Lee, Jae Hoon Lee, Chul Won Jung, Jin Seok Ahn, Kyoo-Hyung Lee, Young Don Joo

Blood (2007) 110 (11): 1092.

https://doi.org/10.1182/blood.V110.11.1092.1092

Published: 2007

Journal Articles

Clinical Features and Prognosis of MDS Patients with Chromosome 5 Abnormalities Other Than ‘5q-Syndrome’: Results of Multi-Center Analysis in Korea.

Blood (2007) 110 (11): 4618.

https://doi.org/10.1182/blood.V110.11.4618.4618

Published: 2007

Journal Articles

Comparison of the Peripheral Blood Stem Cell Mobilization and Harvest after Each Consolidation Chemotherapy in Patients with Acute Myeloid Leukemia in First Complete Remission Who Underwent Autologous Stem Cell Transplantation.

Ho-Jin Shin, Joo Seop Chung, Young Jin Choi, Je-Jung Lee, Sang Kyun Sohn, Goon Jae Cho, Hyeoung-Joon Kim, Deok-Hwan Yang, Jin Ho Back

Blood (2005) 106 (11): 5495.

https://doi.org/10.1182/blood.V106.11.5495.5495

Published: 2005

NARROW

Predictive Value of 3-Month Early Molecular Response in New Chronic Phase Chronic Myeloid Leukemia Patients Treated with Radotinib

Comparable Outcomes with Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients with or without Aplastic Anemia in a Prospective Korean PNH Registry

Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients: 12 Months Result of Phase 3 Clinical Trial

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia

Efficacy and Safety of Deferasirox Estimated By Serum Ferritin and Labile Plasma Iron Levels in Patients with Aplastic Anemia, Myelodysplastic Syndrome, or Hematologic Malignancy with Transfusional Iron Overload

Ineffective Corticosteroid Treatment for Hemolysis Management of Paroxysmal Nocturnal Hemoglobinuria

Role Of Hypomethylating Agents For Patients With Lower-Risk Myelodysplastic Syndrome Defined By IPSS and IPSS-R

Restrospective Multicenter Study Evaluating Efficacy and Safety of Dasatinib and Nilotinib in Patients with Imatinib-Resistant or –intolerant Chronic Myeloid Leukemia in Chronic Phase: Korean CML Working Party

Metabolic Tumor Volume Has Potential Clinical Impact Compared with SUVmax in Primary Gastrointestinal Diffuse Large B Cell lymphoma

Early Response to Botezomib Combined Chemotherapy Can Be Helpful for Prediction of Progression Free Survival in Patients with Multiple Myeloma Who Were Ineligible for Stem Cell Transplantation

The Immunohistochemical Profile and Other Prognostic Factors In Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with R-CHOP

Dasatinib for Chronic Phase Chronic Myeloid Leukemia After Failure of Imatinib In Korean Patients.

Clinical Implications of Clonal Cytogenetic Abnormalities of Aquired Aplastic Anemia.

Sequential VAD (Vincristine, Adriamycin, Dexamethasone) and VTD (Bortezomib, Thalidomide, Dexamethasone) Induction Followed by High-Dose Therapy with Autologous Stem Cell Transplantation and Maintenance Treatment with Bortezomib for Newly Diagnosed Multiple Myeloma: Final Analysis of Phase II Trial.

Comparing Standard IPI with Revised-IPI in Patients with Diffuse Large B-Cell Lymphoma: Which Has a More Differential Potential for Predicting the Outcomes after R-CHOP Chemotherapy.

Velcade ® , Thalidomide, Dexamethasone (VTD) Followed by Melphalan, Prednisone, Thalidomide (MPT) Maintenance as a First Line Treatment Demonstrates High Response Rates for High-Risk Patients with Multiple Myeloma (MM) Who Are Non-Transplant Candidates: Updated Results of Phase II Trial

Clinical Efficacy of VEL-CTD (Bortezomib, Cyclophosphamide, Thalidomide, and Dexamethasone) Regimen in Patients with Relapsed or Refractory Multiple Myeloma: A Phase II Study

Allogeneic Stem Cell Transplantation Can Be an Effective Post-Remission Strategy for Acute Myeloid Leukemia Patients Aged Less Than 60 Years with Core Binding Factor: A Nation-Wide Retrospective Study in Korea.

Clinical Features and Prognosis of MDS Patients with Chromosome 5 Abnormalities Other Than ‘5q-Syndrome’: Results of Multi-Center Analysis in Korea.

Comparison of the Peripheral Blood Stem Cell Mobilization and Harvest after Each Consolidation Chemotherapy in Patients with Acute Myeloid Leukemia in First Complete Remission Who Underwent Autologous Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only